HUMA vs SLS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

HUMA

36.6
AI Score
VS
SLS Wins

SLS

59.9
AI Score

Investment Advisor Scores

HUMA

37score
Recommendation
AVOID NEW MONEY

SLS

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUMA SLS Winner
Forward P/E 35.8423 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 36.5% -82.5% HUMA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.6/100 59.9/100 SLS
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD SLS

Relative Price Performance (Last 90 Days)

HUMA 1M: +27.1% · 3M: -0.4% SLS 1M: -30.7% · 3M: -39.5%

Current Technical Phase

HUMA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.4 · Price: $0.56

SLS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.2%), weak momentum, RSI 35

RSI (14): 34.7 · Price: $7.86

Fundamentals Snapshot

Metric HUMA SLS
Market Cap — —
Forward P/E -2.1 -78.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% -0.8%
Gross Margin -10.6% —
Operating Margin -45.7% 0.0%
EPS -0.45 -0.21
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SLS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.